Head-to-head · WeighScore
Sunlight.com vs Superior Remedies
By GLP-1 ScorecardUpdated
Score comparison
Sunlight.com has the higher recorded score — 83.7/100 to 57.5/100.
Sunlight.com grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Sunlight advertises low flat monthly rates and now names its pharmacy network. Its public pages leave enough uncertainty about the selected payment and shipping timeline that the final plan needs a closer look.
Before you choose
Before comparing the headline prices, the Sunlight.com review and the Superior Remedies review set out the plan length, renewal date and extra fees behind each semaglutide figure in the table below, and the semaglutide cost page compares published rates across the field. A lower starting price can still mean a larger bill once a longer commitment or a separate membership is added.
If neither one fits, Sunlight.com vs T2D.com and Superior Remedies vs Trimi compare each of them with another graded program, and the list of alternatives to Sunlight.com ranks the programs closest to Sunlight.com on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.
Of the sellers that pay us a commission, the Collective review covers one graded close to these two, at 71.6/100. That relationship never changes a grade, and the review lists what we could not verify.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | Sunlight.com | Superior Remedies |
|---|---|---|
| WeighScore | 83.7/100 | 57.5/100 |
| Grade | B | C |
| Site position | #22 | #429 |
| Semaglutide | From $78/month advertised (early Black Friday banner); confirm charge and term | Not disclosed by drug (site advertises a limited-time $149 a month offer) |
| Tirzepatide | From $139/month advertised (early Black Friday banner); confirm charge and term | Not disclosed by drug (site advertises a limited-time $149 a month offer) |
| Coverage | Nationwide platform; treatment availability varies by state | 7 states (CA, IL, MI, NY, UT, VA, WI) |
| Brand-name access | Not confirmed | Not confirmed |
| Oral / sublingual | Not confirmed | Not confirmed |
Strengths
- Public FAQ advertises semaglutide from $78 and tirzepatide from $139 monthly
- Names six pharmacy partners and the Lion MD clinical network
- Medication if approved, telehealth visits and shipping are included
What to consider
- Exact payment and any prepaid commitment were not verified without completing intake; the advertised rate fell from $88 and $157 in October and sits under a seasonal banner
- Landing-page shipping claims differ from the FAQ’s within-seven-business-days statement
- Oral options appear in marketing but no specific oral GLP-1 offer was confirmed
- Refunds are unavailable once a prescription is written and sent to the pharmacy
Strengths
- Runs a dedicated GLP-1 Microdose program with its own page, framed for metabolic health and body composition rather than aggressive weight loss
- Publishes a clinical exclusion that turns business away: patients with significant weight to lose are told they would be better served by a standard GLP-1 protocol
- Charges nothing if you are not approved
- Names its exclusions plainly, including medullary thyroid carcinoma or MEN 2 history and pregnancy
What to consider
- No price on any program page — the only public figure is a homepage headline labeled a limited-time offer and attached to the general pitch rather than to a program
- No milligram figure anywhere, so "microdose" describes an intent rather than an amount
- No compounding pharmacy is named
- Compounded GLP-1s are not FDA-approved
Featured provider
CoreAge Rx
CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.
Commercial relationships affect this placement. The score comparison above is separate.
Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.